If you're looking for biooncology.com.com's Adword's Competitors iSpionage Competitor Research is the right product for you
Top Competitors for biooncology.com
| PPC Budget | # Keywords | # Overlap kw | ||
|---|---|---|---|---|
| prescriptiontreatmentwebsite | $784,154 | 110,530 | 20 | Learn More |
| cancercenter.com | $59,344 | 16,970 | 9 | Learn More |
| abcam.com | $5,887 | 2,268 | 7 | Learn More |
| atum.bio | $157 | 93 | 5 | Learn More |
| abclonal.com | $1,307 | 1,391 | 5 | Learn More |
Competitor offers & landing pages
Sample SEO Keywords for: biooncology.com
Organic Listings | 1st Page Keywords | Avg Pos | Pos Trend | Est.Traffic | Traffic Value | |
|---|---|---|---|---|---|---|
Monoclonal Antibodies | BioOncology https://www.biooncology.com/deExpanding on a heritage of gro | 17 | 17.88 ( 4.04 ) | 11880 | $1,522 | ||
| Keyword | Position | Trend | Search Vol | CPC | ||
| antibody monoclonal | 6 | 10 | N /A | |||
| monoclonal antibody | 10 | 2,900 | $7.91 | |||
| monoclone antibody | 11 | 10 | N /A | |||
| monoclonal antibodies | 16 | 6,600 | $8.11 | |||
| monoclonal antibodies and cancer | 17 | 10 | N /A | |||
PD-L1 Inhibitor + MEK, VEGF, Antigen | BioOncology https://www.biooncology.com/paLearn how PD-L1 inhibition is | 8 | 3.5 ( 1.5 ) | 3950 | $133 | ||
| Keyword | Position | Trend | Search Vol | CPC | ||
| pdl 1 | 3 ( 1 ) | 320 | $8.79 | |||
| pdl1 | 4 | 880 | $9.79 | |||
| pd-l1 | 4 | 880 | $10.4 | |||
| pd l1 | 4 | 880 | $10.4 | |||
| pdl-1 | 4 | 320 | $8.79 | |||
Sample PPC Keywords for: biooncology.com
Top Ads
Cancer Tumor Markers - Visit Official HCP Website Find Out More Information About Research Pertaining To Tumor Mechanisms. Platforms. Types: Immune Desert, Immune Excluded, Inflamed. www.biooncology.com/TumorMarkers Tumor Targets Find Out More Information About Research Pertaining To Tumor Mechanisms & Types. Platforms. Types: Immune Desert, Immune Excluded, Inflamed. www.biooncology.com/TumorType Cancer Tumor Types - Visit Official HCP Website Find Out More Information About Research Pertaining To Tumor Mechanisms & Types. Platforms. Types: Immune Desert, Immune Excluded, Inflamed. www.biooncology.com/TumorType PD-L1 Tumor Target - Genentech BioOncology Website Visit The HCP Website To Learn About Research Regarding PD-L1 Tumor Targets. Platforms. Types: Immune Desert, Immune Excluded, Inflamed. www.biooncology.com/TumorTarget | |||
Cancer Tumor Markers - Genentech BioOncology Website Visit The HCP Website For More Info About Tumor Mechanisms & Cancer Immunity. www.biooncology.com/TumorMarkers Monoclonal Antibodies | Find Out More Information | BioOncology.com Discover How mABs are Used in Combination with Chemotherapy to Create ADCs. Chemotherapy. www.biooncology.com/ADC PD-L1 Tumor Target - Genentech BioOncology Website Visit The HCP Website To Learn About Research Regarding PD-L1 Tumor Targets. Platforms. www.biooncology.com/TumorTarget Disease Pathways Visit The HCP Website For More Info About Tumor Types & Cancer Immunity. Platforms. Types: Immune Desert, Immune Excluded, Inflamed. www.biooncology.com/TumorType | |||
Cancer Tumor Markers - Visit Official HCP Website Find Out More Information About Research Pertaining To Tumor Mechanisms. www.biooncology.com/TumorMarkers Cancer Immunology Research - Official HCP Website Learn About Scientific Research Regarding Different Cancer Immunity Targets. Platforms. Types: Immune Desert, Immune Excluded, Inflamed. www.biooncology.com/Cancer/Immunology Cancer Immunology Targets - Visit Official HCP Website Learn More Info About Biomedical Research Regarding Cancer Immunology Targets. Platforms. Types: Immune Desert, Immune Excluded, Inflamed. www.biooncology.com/CancerImmunity Monoclonal Antibodies | Find Out More Information | BioOncology.com Discover How mABs are Used in Combination with Chemotherapy to Create ADCs. CD79B. www.biooncology.com/ | |||
Monoclonal Antibodies | Genentech BioOncology Website Discover How mABs are Used in Combination with Chemotherapy to Create ADCs. Chemotherapy. CD79B. Antibody Drug Conjugates. Types: Monoclonal Antibodies, Potent Cytotoxins, Stable Linker, ADC. www.biooncology.com/ PD-L1 Tumor Target - Visit Official HCP Website Learn More Information About Biomedical Research On PD-L1 Tumor Targets. Platforms. Types: Immune Desert, Immune Excluded, Inflamed. www.biooncology.com/TumorTarget Cancer Immunology Research - Official HCP Website Learn About Scientific Research Regarding Different Cancer Immunity Targets. Platforms. www.biooncology.com/Cancer/Immunology CD3 Antibody Cancer Research - Genentech BioOncology Website Visit The HCP Website To Learn Info About Research Regarding Cancer Targets. Platforms. www.biooncology.com/CancerImmunity | |||
Monoclonal Antibodies | Genentech BioOncology Website Discover How mABs are Used in Combination with Chemotherapy to Create ADCs. Chemotherapy. Antibody Drug Conjugates. CD79B. Types: Monoclonal Antibodies, Potent Cytotoxins, Stable Linker, ADC. www.biooncology.com/ T-cell Bispecific Antibodies - Visit Official HCP Website Learn More From Research About The Role Of Multiple Immune Mechanisms. Platforms. Types: Immune Desert, Immune Excluded, Inflamed. www.biooncology.com/CancerImmunity Diffuse Large B Cell Lymphoma - Physician Education Site Discover the Potential of CD79b as a Target in Diffuse Large B Cell Lymphoma. CD79B. DLBCL. Non Hodgkin Lymphoma. Types: Failed 1st-Line Treatment, Targeting, Internalization, Degradation. www.biooncology.com/CD79B CEA Cancer Immunity - Genentech BioOncology Website Visit The HCP Website To Learn More Info About Research On Targeting CEA. Platforms. Types: Immune Desert, Immune Excluded, Inflamed. www.biooncology.com/CancerImmunity | |||
Cancer Tumor Markers | Visit Official HCP Website Find Out More Information About Research Pertaining To Tumor Mechanisms. www.biooncology.com/TumorMarkers Cancer Tumor Types - Genentech BioOncology Website Visit The HCP Website For More Info About Tumor Types & Cancer Immunity. Platforms. Types: Immune Desert, Immune Excluded, Inflamed. www.biooncology.com/TumorType Antibody Drug Conjugates - Find Out More Information Discover How Antibody Drug Conjugates Can Actively Target & Kill Malignant Cells. CD79B. www.biooncology.com/ADC Cancer Tumor Types - Genentech BioOncology Website Visit The HCP Website For More Info About Tumor Types & Cancer Immunity. www.biooncology.com/TumorType | |||
Monoclonal Antibodies | Find Out More Information | BioOncology.com Discover How mABs are Used in Combination with Chemotherapy to Create ADCs. Antibody Drug Conjugates. Chemotherapy. CD79B. Types: Monoclonal Antibodies, Potent Cytotoxins, Stable Linker, ADC. www.biooncology.com/ADC Cancer Immunology Targets - Genentech BioOncology Website Visit The HCP Website To Learn More Info About Research On Cancer Targets. Platforms. Types: Immune Desert, Immune Excluded, Inflamed. www.biooncology.com/CancerImmunity Monoclonal Antibodies | Genentech BioOncology Website Discover How mABs are Used in Combination with Chemotherapy to Create ADCs. Chemotherapy. Antibody Drug Conjugates. CD79B. Types: Monoclonal Antibodies, Potent Cytotoxins, Stable Linker, ADC. www.biooncology.com/ADC Antibody Drug Conjugates - Genentech BioOncology Website Discover How Antibody Drug Conjugates Can Actively Target & Kill Malignant Cells. Chemotherapy. CD79B. Types: Monoclonal Antibodies, Potent Cytotoxins, Stable Linker, ADC. www.biooncology.com/ADC | |||
Tumor Targets Find Out More Information About Research Pertaining To Tumor Mechanisms. www.biooncology.com/TumorMarkers Cancer Tumor Markers - Genentech BioOncology Website Visit The HCP Website For More Info About Tumor Mechanisms & Cancer Immunity. Platforms. Types: Immune Desert, Immune Excluded, Inflamed. www.biooncology.com/TumorMarkers Genitourinary Cancer - Visit Official HCP Website Learn More Information About Research Regarding Pathways To Treat Malignancies. Platforms. www.biooncology.com/CancerPathways Monoclonal Antibodies Discover How mABs are Used in Combination with Chemotherapy to Create ADCs. www.biooncology.com/ADC | |||
Non Hodgkin Lymphoma - Physician Education Site Learn How Targeting CD79b May Provide Help to Patients Dealing with NHL. www.biooncology.com/CD79B Visit Official HCP Website - Cancer Immunity Research Get More Information About Findings Pertaining To Cancer Immunity. Platforms. www.biooncology.com/CancerImmunity Lung Cancer - Genentech BioOncology Website Explore Research Results Regarding Molecular Pathways Found In Lung Cancer. Platforms. Types: Immune Desert, Immune Excluded, Inflamed. www.biooncology.com/CancerPathways Tumor Targets Discover the Potential of CD79b as a Target in Diffuse Large B Cell Lymphoma. DLBCL. Non Hodgkin Lymphoma. CD79B. Types: Failed 1st-Line Treatment, Targeting, Internalization. www.biooncology.com/CD79B | |||
Tumor Targets Visit The HCP Website For More Info About Tumor Mechanisms & Cancer Immunity. Platforms. www.biooncology.com/TumorMarkers T-cell Bispecific Antibodies - Genentech BioOncology Website Find Info About The Role Of T-cell Bispecific Antibodies & Immune Mechanisms. Platforms. Types: Immune Desert, Immune Excluded, Inflamed. www.biooncology.com/CancerImmunity Tumor Targets Visit The HCP Website For More Info About Tumor Mechanisms & Cancer Immunity. Platforms. Types: Immune Desert, Immune Excluded, Inflamed. www.biooncology.com/TumorMarkers Cancer Tumor Markers - Genentech BioOncology Website Visit The HCP Website For More Info About Tumor Mechanisms & Cancer Immunity. Platforms. www.biooncology.com/TumorMarkers | |||
